Abstract
Microphthalmia, Anophthalmia and Coloboma (MAC) form a spectrum of congenital eye malformations responsible for severe visual impairment. Despite the exploration of hundreds of genes by High-Throughput Sequencing (HTS), most of the patients remain without genetic diagnosis. One explanation could be the not yet demonstrated involvement of somatic mosaicism (undetected by conventional analysis pipelines) in those patients. Furthermore, the proportion of parental germline mosaicism in presumed de novo variations is still unknown in ocular malformations. Thus, using dedicated bioinformatics pipeline designed to detect mosaic variants, we reanalysed the sequencing data obtained from a 119 ocular development genes panel performed on blood samples of 78 probands with sporadic MAC without genetic diagnosis. Using the same HTS strategy, we sequenced 80 asymptomatic parents of 41 probands carrying a disease-causing variant in an ocular development gene considered de novo after Sanger sequencing of both parents. Reanalysis of the previously sequencing data did not find any mosaic variant in probands without genetic diagnosis. However, HTS of parents revealed undetected SOX2 and PAX6 mosaic variants in two parents. Finally, this work, performed on two large cohorts of patients with MAC spectrum, provides for the first time an overview of the interest of looking for mosaicism in ocular development disorders. Somatic mosaicism does not appear to be frequent in MAC spectrum and might explain only few diagnoses. Thus, other approaches such as whole genome sequencing should be considered in those patients. Parental mosaicism is however not that rare (around 5%) and challenging for genetic counselling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data generated or analysed during this study are included in this published article and its supplementary information files. Newly described variants have been added to ClinVar database (SCV002583597 - SCV002583623).
Change history
29 November 2022
All authors’ surnames and given names had been swapped.
02 December 2022
A Correction to this paper has been published: https://doi.org/10.1038/s41431-022-01254-z
References
Plaisancié J, Ceroni F, Holt R, Zazo Seco C, Calvas P, Chassaing N, et al. Genetics of anophthalmia and microphthalmia. Part 1: non-syndromic anophthalmia/microphthalmia. Hum Genet. 2019;138:799–830.
Slavotinek A. Genetics of anophthalmia and microphthalmia. Part 2: syndromes associated with anophthalmia–microphthalmia. Hum Genet. 2019;138:831–46.
Patel N, Khan AO, Alsahli S, Abdel-Salam G, Nowilaty SR, Mansour AM, et al. Genetic investigation of 93 families with microphthalmia or posterior microphthalmos. Clin Genet. 2018;93:1210–22.
Haug P, Koller S, Maggi J, Lang E, Feil S, Wlodarczyk A, et al. Whole exome sequencing in coloboma/microphthalmia: identification of novel and recurrent variants in seven genes. Genes. 2021;12:65.
Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565–75.
Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet C Semin Med Genet. 2014;166:397–405.
Stosser MB, Lindy AS, Butler E, Retterer K, Piccirillo-Stosser CM, Richard G, et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet Med. 2018;20:403–10.
Erickson RP. Somatic gene mutation and human disease other than cancer: an update. Mutat Res. 2010;705:96–106.
Acuna-Hidalgo R, Bo T, Kwint MP, van de Vorst M, Pinelli M, Veltman JA, et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am J Hum Genet. 2015;97:67–74.
Tarilonte M, Morín M, Ramos P, Galdós M, Blanco-Kelly F, Villaverde C, et al. Parental mosaicism in PAX6 causes intra-familial variability: implications for genetic counseling of congenital aniridia and microphthalmia. Front Genet. 2018;9:479.
Chassaing N, Gilbert-Dussardier B, Nicot F, Fermeaux V, Encha-Razavi F, Fiorenza M, et al. Germinal mosaicism and familial recurrence of a SOX2 mutation with highly variable phenotypic expression extending from AEG syndrome to absence of ocular involvement. Am J Med Genet A. 2007;143A:289–91.
Faivre L, Williamson KA, Faber V, Laurent N, Grimaldi M, Thauvin-Robinet C, et al. Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother. Am J Med Genet A. 2006;140:636–9.
Suzuki J, Azuma N, Dateki S, Soneda S, Muroya K, Yamamoto Y, et al. Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities. J Hum Genet. 2014;59:353–6.
Plaisancié J, Tarilonte M, Ramos P, Jeanton-Scaramouche C, Gaston V, Dollfus H, et al. Implication of non-coding PAX6 mutations in aniridia. Hum Genet. 2018;137:831–46.
Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10.
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.
Benjamin D, Sato T, Cibulskis K, Getz G, Stewart C, Lichtenstein L. Calling Somatic SNVs and Indels with Mutect2. 2019:861054.
Lai Z, Markovets A, Ahdesmaki M, Chapman B, Hofmann O, McEwen R, et al. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res. 2016;44:e108–e108.
Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. 2012.arXiv:1207.3907v2 [q-bio.GN].
Wright CF, Prigmore E, Rajan D, Handsaker J, McRae J, Kaplanis J, et al. Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data. Nat Commun. 2019;10:2985.
King DA, Sifrim A, Fitzgerald TW, Rahbari R, Hobson E, Homfray T, et al. Detection of structural mosaicism from targeted and whole-genome sequencing data. Genome Res. 2017;27:1704–14.
Nizon M, Henry M, Michot C, Baumann C, Bazin A, Bessières B, et al. A series of 38 novel germline and somatic mutations of NIPBL in Cornelia de Lange syndrome. Clin Genet. 2016;89:584–9.
Kline AD, Moss JF, Selicorni A, Bisgaard A-M, Deardorff MA, Gillett PM, et al. Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet. 2018;19:649–66.
Daich Varela M, Hufnagel RB, Guan B, Blain D, Sapp JC, Gropman AL, et al. Clinical diagnosis of presumed SOX2 gonadosomatic mosaicism. Ophthalmic Genet. 2021;42:320–5.
Ohuchi H, Sato K, Habuta M, Fujita H, Bando T. Congenital eye anomalies: more mosaic than thought? Congenit Anom. 2019;59:56–73.
Shima H, Ishii A, Wada Y, Kizawa J, Yokoi T, Azuma N, et al. SOX2 nonsense mutation in a patient clinically diagnosed with non-syndromic hypogonadotropic hypogonadism. Endocr J. 2017;64:813–7.
Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, Clarke MP, et al. Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet. 2005;76:1008–22.
Robinson DO, Howarth RJ, Williamson KA, Heyningen V, van, Beal SJ, Crolla JA. Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia. Am J Med Genet A. 2008;146A:558–69.
Mitsuhashi S, Matsumoto N. Long-read sequencing for rare human genetic diseases. J Hum Genet. 2020;65:11–19.
Dai C, Cheng D, Li W, Zeng S, Lu G, Zhang Q. Identification of paternal germline mosaicism by MicroSeq and targeted next‐generation sequencing. Mol Genet Genomic Med. 2020;8. https://doi.org/10.1002/mgg3.1394.
Acknowledgements
We appreciated the generous support received from patients and their families and are grateful for the contributions of physicians who evaluated or followed up patients with ocular malformation.
Funding
Patients were recruited through the Rare Diseases Cohorts (RaDiCo) programme which is funded by the French National Research Agency under the specific programme “Investments for the Future”, Cohort grant agreement ANR-10-COHO-0003.
Author information
Authors and Affiliations
Contributions
All authors have actively participated in data collection or interpretation and have revised and approved the manuscript. BC and JP designed experiments and write the first version of manuscript. GM, YC, CVD, PC collected data from patients. VG performed sequencing. VI, CH, and FE performed bioinformatic analysis. BC, NC, and JP performed analysis and interpretation.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
Patients gave informed consent to genetic analyses and research. This study is a retrospective study based on the exploitation of usual care data. A submission at an ethic committee is not required according to the French ethic and regulatory law (public health code).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: All authors’ surnames and given names had been swapped.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chesneau, B., Ivashchenko, V., Habib, C. et al. Evaluation of somatic and/or germline mosaicism in congenital malformation of the eye. Eur J Hum Genet 31, 526–530 (2023). https://doi.org/10.1038/s41431-022-01234-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-022-01234-3